NTRA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Natera Inc (NTRA) is not a strong buy for a beginner, long-term investor at this moment. While the company has strong growth potential and positive analyst sentiment, the recent financial performance shows a significant drop in net income and EPS. Additionally, technical indicators suggest a neutral to slightly bearish short-term trend, and there are no strong proprietary trading signals or recent congress trading data to support an immediate buy decision.
The MACD is positive but contracting, indicating weakening bullish momentum. RSI is neutral at 41.802, suggesting no clear overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below the pivot level of 202.961, with key support at 189.209 and resistance at 216.713. Short-term stock trend analysis predicts a potential decline of -2.66% in the next day and -5.61% in the next week.
The company has a diversified portfolio in diagnostics and is positioned for long-term growth.
The stock is predicted to decline in the short term based on historical candlestick patterns. Insider trading activity is neutral, and there is no recent congress trading data to provide additional confidence.
In Q4 2025, revenue increased by 39.79% YoY to $665.5 million, showing strong top-line growth. However, net income dropped significantly by -187.89% YoY to $47.26 million, and EPS fell by -182.93% YoY to 0.34. Gross margin improved to 66.67%, up 5.93% YoY, indicating better operational efficiency.
Analysts are generally positive on Natera, with multiple Buy and Outperform ratings. Recent price target changes include Citi's $300 target and UBS's $290 target, reflecting optimism about the company's growth potential. However, some firms, like Evercore ISI and Morgan Stanley, have slightly lowered their price targets while maintaining positive ratings.
